London Lab Showcase Report 2025
Lab spaceHow London’s expanding lab network is reshaping supply, cost and opportunity for growing life sciences companies.
Overview
London’s lab market is evolving rapidly as new developments ease years of undersupply. A broader pipeline of projects across districts such as White City, King’s Cross and Canary Wharf is reshaping supply and competition. Developers are focusing on wet-lab capability, flexible footprints and improved access to shared resources.
Costs are rising as modern, higher-spec facilities come online, but greater choice is helping tenants find space that fits their stage of growth. MedCity’s analysis shows a more balanced market emerging by 2030, supported by continued investment in innovation districts and transport-connected sites that attract global life sciences firms.
Key takeaways
- Pipeline momentumLondon’s lab stock is expanding faster than at any point in the past decade as new schemes move from planning to delivery across multiple innovation districts.
- Flexible design focusRecent developments emphasise wet-lab provision, modular floorplates and access to shared infrastructure, offering more flexibility for early-stage and scaling companies.
- Competitive but resilient marketIncreased supply is adding competition and moderating demand pressures, but pricing remains stable in prime clusters where high-quality space continues to outperform.
